• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

AbbVie enters partnership with iStar with option to acquire

July 20, 2022 By Sean Whooley

MINIject iSTAR

AbbVie (NYSE:ABBV) announced today that it entered into a strategic alliance with iStar Medical over the MINIject device. The strategic transaction centers around helping to further develop and commercialize iStar’s MINIject minimally invasive glaucoma surgical (MIGS) device. It will also provide AbbVie with a chance to expand its eye care business through an option to […]

Filed Under: Business/Financial News, Clinical Trials, Drug-Device Combinations, Featured, Funding Roundup, Implants, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: AbbVie, iSTAR Medical

MIT researchers think microparticles could deliver ‘self-boosting’ vaccines

July 19, 2022 By Sean Whooley

MIT Self Boosting Vaccine

MIT researchers are touting microparticles that can deliver payloads at different points, potentially creating “self-boosting” vaccines. A new study, highlighted on the institute’s news website, demonstrates a way in which researchers could design vaccines that would need to be given just once before they “self-boost,” or essentially re-deliver the therapeutic, at a specified point in […]

Filed Under: Drug-Device Combinations, Nanoparticles, Pharmaceuticals, Research & Development Tagged With: Massachusetts Institute of Technology, mit

Study backs One Drop’s AI-powered blood glucose forecasts in diabetes outcomes

July 19, 2022 By Sean Whooley

One Drop

One Drop announced today that a study of its AI-powered blood glucose forecasting technology leads to improved diabetes outcomes. New York-based One Drop published outcomes from a retrospective cohort study in the Journal of Medical Internet Research (JMIR). The study focused on indicators of glycemic control and health data logging in adults with type 2 diabetes using […]

Filed Under: Big Data, Clinical Trials, Diabetes, Drug-Device Combinations, Patient Monitoring, Technology Tagged With: One Drop

6 drug delivery innovations you need to know

July 19, 2022 By Sean Whooley

6 Drug Delivery Innovations you should know abbott xience vivera zicoh novaxs insulet omnipod 5

From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Pharmaceuticals Tagged With: abbott, BD, Bigfoot Biomedical, cequr, cook medical, Dexcom, Insulet, Jabil Healthcare, Johnson & Johnson, Johnson & Johnson Vision, Medtronic, NovaXS, PharmaJet, Phillips-Medisize, Senseonics, Vivera

UnitedHealthcare to eliminate out-of-pocket costs on insulin, other prescription drugs

July 15, 2022 By Sean Whooley

Unitedhealthcare logo

UnitedHealthcare announced today that it will eliminate out-of-pocket costs in standard fully insured group plans for certain prescription drugs. Insulin, among a number of drugs used to treat emergencies including severe allergic reactions, hypoglycemia, opioid overdoses, and acute asthma attacks will be included in the new standard offering. Along with insulin, epinephrine (for severe allergic […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: insulin, UnitedHealthcare

Data supports GI Dynamics’ type 2 diabetes treatment

July 14, 2022 By Sean Whooley

GI Dynamics Logo

GI Dynamics announced today that results from a registry for its EndoBarrier for type 2 diabetes were positive. Data from use of the EndoBarrier within the National Health Service (NHS) in the UK were presented by Dr. Robert Ryder of City Hospital (Birmingham, UK) at the American Diabetes Association Scientific Sessions last month, according to […]

Filed Under: Clinical Trials, Diabetes, Surgical Tagged With: GI Dynamics

Longenesis, Medtronic study says quality of life improves with insulin pumps for T1D patients

July 13, 2022 By Sean Whooley

Longenesis medtronic

Longenesis announced today that a study on type 1 diabetes care, in partnership with Medtronic (NYSE:MDT), supports insulin pump use. Across less than three months, more than 85 patients participated in the research study aimed at providing qualitative and quantitative data on the quality of life for type 1 diabetics using insulin pumps compared to […]

Filed Under: Auto-injectors, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured Tagged With: Longenesis, Medtronic

Smiths Medical warns on 8 potential issues with infusion pumps

July 13, 2022 By Sean Whooley

Smiths Medical

Smiths Medical issued an urgent field safety notice in Europe regarding its Medfusion 3500 and 4000 infusion pumps. The company issued the letter to notify on eight potential issues with its pumps. The issues include false alarms, unanticipated depleted battery alarms and abnormal circuit board behavior causing internal clock system failure. Additionally, issues with intermittent […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Recalls Tagged With: Smiths Medical

Readout Health wins JDRF grant to evaluate handheld breath ketone monitor

July 12, 2022 By Sean Whooley

Readout Health Biosense Device health app

Readout Health announced today that it entered into a sponsored research agreement with Washington University School of Medicine. The agreement with Washington University School of Medicine (St. Louis) includes a two-year, $360,000 research grant from JDRF to test the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during usual […]

Filed Under: Big Data, Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring Tagged With: Juvenile Diabetes Research Foundation (JDRF), Readout Health

Vertex to acquire stem cell-derived diabetes treatment maker ViaCyte for $320M

July 11, 2022 By Sean Whooley

Vertex Pharmaceuticals ViaCyte

Vertex Pharmaceuticals (Nasdaq:VRTX) announced today that it agreed to acquire ViaCyte for $320 million. San Diego-based ViaCyte develops an advanced portfolio of novel stem cell-derived replacement therapies designed to provide a functional cure for patients with type 1 diabetes. Boston-based Vertex develops its own similar therapeutic for diabetes, having designed its VX-880 as a stem […]

Filed Under: Business/Financial News, Diabetes, Featured, Mergers & Acquisitions, Stem Cells Tagged With: Vertex Pharmaceuticals, ViaCyte

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Interim pages omitted …
  • Go to page 80
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS